NorthRock Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Buy |
12,922
+1,290
| +11% | +$143K | 0.04% | 176 |
|
|
2025
Q1 | $1.3M | Buy |
11,632
+425
| +4% | +$47.6K | 0.04% | 168 |
|
|
2024
Q4 | $1.04M | Buy |
11,207
+920
| +9% | +$85K | 0.03% | 197 |
|
|
2024
Q3 | $862K | Buy |
10,287
+1,276
| +14% | +$107K | 0.03% | 234 |
|
|
2024
Q2 | $618K | Sell |
9,011
-264
| -3% | -$18.1K | 0.02% | 289 |
|
|
2024
Q1 | $679K | Sell |
9,275
-1,623
| -15% | -$119K | 0.03% | 276 |
|
|
2023
Q4 | $883K | Buy |
10,898
+7,082
| +186% | +$574K | 0.04% | 211 |
|
|
2023
Q3 | $286K | Buy |
3,816
+96
| +3% | +$7.2K | 0.03% | 243 |
|
|
2023
Q2 | $287K | Sell |
3,720
-470
| -11% | -$36.2K | 0.03% | 221 |
|
|
2023
Q1 | $348K | Sell |
4,190
-583
| -12% | -$48.4K | 0.04% | 198 |
|
|
2022
Q4 | $410K | Buy |
4,773
+633
| +15% | +$54.3K | 0.05% | 186 |
|
|
2022
Q3 | $255K | Buy |
4,140
+445
| +12% | +$27.4K | 0.03% | 239 |
|
|
2022
Q2 | $228K | Buy |
+3,695
| New | +$228K | 0.02% | 271 |
|
|
2022
Q1 | – | Sell |
-2,768
| Closed | -$201K | – | 346 |
|
|
2021
Q4 | $201K | Sell |
2,768
-3,554
| -56% | -$258K | 0.02% | 318 |
|
|
2021
Q3 | $442K | Buy |
6,322
+1,009
| +19% | +$70.5K | 0.04% | 167 |
|
|
2021
Q2 | $366K | Buy |
+5,313
| New | +$366K | 0.03% | 174 |
|
|
2020
Q3 | – | Sell |
-3,587
| Closed | -$276K | – | 229 |
|
|
2020
Q2 | $276K | Buy |
3,587
+632
| +21% | +$48.6K | 0.03% | 165 |
|
|
2020
Q1 | $221K | Sell |
2,955
-9,464
| -76% | -$708K | 0.03% | 176 |
|
|
2019
Q4 | $807K | Buy |
12,419
+823
| +7% | +$53.5K | 0.09% | 115 |
|
|
2019
Q3 | $735K | Buy |
+11,596
| New | +$735K | 0.1% | 95 |
|